RecruitingNCT05098769
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using Parameters Obtained by Computed Tomographic Pulmonary Angiography.
Sponsor
Shengjing Hospital
Enrollment
300 participants
Start Date
Jan 18, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography
Exclusion Criteria3
- pregnancy
- reception of reperfusion treatment before admission
- missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05098769
Related Trials
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
NCT054822691 location
Feasibility and Initial Clinical Impressions of Predictive Monitoring Integrated With the RACE Team
NCT051083761 location
Registry of Catheter Intervention in Pulmonary Embolism
NCT063484591 location
Apixaban in Thrombocytopenia
NCT068865161 location
Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy Vs. Thromboaspiration.
NCT060510321 location